1-19 of 19
Authors: Benjamin Liechty
Sort by
Journal Article
SSTR2 expression in neoplastic and normal anterior pituitary is impacted by age, sex, and hormonal status
Get access
Benjamin Liechty and others
Journal of Neuropathology & Experimental Neurology, nlaf034, https://doi.org/10.1093/jnen/nlaf034
Published: 22 April 2025
Journal Article
NIMG-73. RADIOGRAPHIC CHANGES AFTER RADIATION THERAPY IN SUBTOTALLY RESECTED ATYPICAL MENINGIOMAS
Eunji Yim and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v202, https://doi.org/10.1093/neuonc/noad179.0768
Published: 10 November 2023
Journal Article
NIMG-91. DOTATATE PET/MR-GUIDED POSTOPERATIVE MANAGEMENT IN WHO-2 MENINGIOMA: ACTIVE SURVEILLANCE BASED ON PET/MR EVIDENCE OF GROSS TOTAL RESECTION
Jonathan Knisely and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii186, https://doi.org/10.1093/neuonc/noac209.709
Published: 14 November 2022
Journal Article
NIMG-92. DOTATATE PET/MR-GUIDED POSTOPERATIVE RADIOTHERAPY IN SUBTOTALLY RESECTED WHO-2 MENINGIOMA: EVALUATION OF PROGRESSION-FREE SURVIVAL IN A PROSPECTIVE COHORT
Jonathan Knisely and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii186, https://doi.org/10.1093/neuonc/noac209.710
Published: 14 November 2022
Journal Article
PATH-41. POLYMORPHOUS LOW-GRADE NEUROEPITHELIAL TUMOR OF THE YOUNG WITH FGFR3-TACC3 FUSION MIMICKING HIGH-GRADE GLIOMA: CASE REPORT AND SERIES OF HIGH-GRADE CORRELATES
Danielle Golub and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi124, https://doi.org/10.1093/neuonc/noab196.493
Published: 12 November 2021
Journal Article
Outcomes following upfront radiation versus monitoring in atypical meningiomas: 16-year experience at a tertiary medical center
Peter C Pan and others
Neuro-Oncology Advances, Volume 3, Issue 1, January-December 2021, vdab094, https://doi.org/10.1093/noajnl/vdab094
Published: 29 June 2021
Journal Article
43. DELAYS IN ADJUVANT STEREOTACTIC RADIOSURGERY REDUCE LOCAL CONTROL FOR RESECTED BRAIN METASTASES
Diana Roth O’Brien and others
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii8, https://doi.org/10.1093/noajnl/vdaa073.031
Published: 04 August 2020
Journal Article
45. DELAY OR FAILURE TO ADMINISTER STEREOTACTIC RADIOSURGERY TO THE CAVITY AFTER SURGERY FOR BRAIN METASTASES. AN INTENTION-TO-TREAT ANALYSIS
Diana Roth O’Brien and others
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii8–ii9, https://doi.org/10.1093/noajnl/vdaa073.033
Published: 04 August 2020
Journal Article
MNGI-10. ATYPICAL MENINGIOMA: EARLY OUTCOMES WITH OR WITHOUT POSTOPERATIVE RADIATION
Peter Pan and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi141, https://doi.org/10.1093/neuonc/noz175.592
Published: 11 November 2019
Journal Article
MNGI-14. LOSS OF HISTONE H3K27me3 IDENTIFIES A SUBSET OF MENINGIOMAS WITH INCREASED RISK OF RECURRENCE
Leah M Katz and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi151, https://doi.org/10.1093/neuonc/noy148.630
Published: 05 November 2018
Journal Article
GENE-16. CLINICALLY AGGRESSIVE MENINGIOMAS ARE CHARACTERIZED BY MUTATIONAL SIGNATURES ASSOCIATED WITH DEFECTIVE DNA REPAIR AND MUTATIONS IN CHROMATIN REMODELING GENES
Sylvia Kurz and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi106, https://doi.org/10.1093/neuonc/noy148.442
Published: 05 November 2018
Journal Article
IMMU-18. PDL-1 EXPRESSION ON CIRCULATING CD68 (-) MONOCYTE-LIKE CELLS IN NF2 MENINGIOMA AS A BIOMARKER FOR TUMOR PROGRESSION
Shiyang Wang and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i102, https://doi.org/10.1093/neuonc/noy059.334
Published: 22 June 2018
Journal Article
CBIO-19. CHARACTERIZATION OF GPR133 EXPRESSION IN GLIOMA SUBTYPES
Michael Kader and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi36, https://doi.org/10.1093/neuonc/nox168.138
Published: 06 November 2017
Journal Article
RARE-29. PROGRAMMED DEATH LIGAND 1 EXPRESSION AND TUMOR INFILTRATING LYMPHOCYTES IN TUMORS ASSOCIATED WITH NEUROFIBROMATOSIS TYPE 1 AND 2
Shiyang Wang and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi216, https://doi.org/10.1093/neuonc/nox168.873
Published: 06 November 2017
Journal Article
IMMU-04. HIGH FREQUENCY OF PROGRAMMED DEATH LIGAND 1 EXPRESSION IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
Farha Sherani and others
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Page iv28, https://doi.org/10.1093/neuonc/nox083.115
Published: 31 May 2017
Journal Article
IMMU-16. PROGRAMMED DEATH LIGAND 1 EXPRESSION AND TUMOR INFILTRATING LYMPHOCYTES IN TUMORS ASSOCIATED WITH NEUROFIBROMATOSIS TYPE 1 AND 2
Shiyang Wang and others
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Page iv31, https://doi.org/10.1093/neuonc/nox083.126
Published: 31 May 2017
Journal Article
MPTH-59. ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMAS: A CLINICOPATHOLOGIC AND MOLECULAR PROFILE
Devorah Segal and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi118, https://doi.org/10.1093/neuonc/now212.493
Published: 07 November 2016
Journal Article
HG-127ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMAS: A CLINICOPATHOLOGIC AND MOLECULAR PROFILE
Devorah Segal and others
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii77, https://doi.org/10.1093/neuonc/now073.123
Published: 30 May 2016
Journal Article
TB-27SUBGROUP-SPECIFIC OUTCOMES OF CHILDREN WITH MALIGNANT CHILDHOOD BRAIN TUMORS TREATED WITH AN IRRADIATION-SPARING PROTOCOL
Eveline Teresa Hidalgo and others
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii173, https://doi.org/10.1093/neuonc/now084.19
Published: 30 May 2016